Elevation of pulmonary artery pressure as a complication of nilotinib therapy for chronic myeloid leukemia.
We present the case of a 72-year-old male with chronic phase myeloid leukemia. Elevation of the pulmonary artery pressure due to nilotinib therapy was noted. This effect on pulmonary artery pressure was nilotinib dose dependent.